SCHEMBL7313843

SCHEMBL7313843

COc1ccc(S(=O)(=O)Nc2cc3ccccc3cc2C(=O)O)cc1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.60
KDM4E B2RXH2 2/20 0.60
RCE1 Q9Y256 1/20 0.60
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
KEAP1 Q14145 3/20 0.58
NFE2L2 Q16236 2/20 0.58
SQSTM1 Q13501 1/20 0.58
CYP2C9 P11712 2/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2C19 P33261 1/20 0.58
LMNA P02545 2/20 0.56
TP53 P04637 1/20 0.56
HPGD P15428 1/20 0.56
HTT P42858 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
GAA P10253 1/20 0.56
POLB P06746 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23200358 0.86 METAP2 (0.68) ALDH1A1MEN1KMT2AKEAP1NFE2L2
SCHEMBL30486834 0.85 LMNA (0.70) ALDH1A1KDM4EMEN1KMT2AKEAP1
SCHEMBL2477690 0.85 LMNA (0.70) ALDH1A1KDM4EMEN1KMT2AKEAP1
SCHEMBL14075396 0.83 CYP2C9 (0.73) ALDH1A1KDM4ERCE1KEAP1NFE2L2
SCHEMBL7322109 0.82 METAP2 (0.73) ALDH1A1KDM4ERCE1KEAP1NFE2L2
SCHEMBL7316092 0.82 CYP2C9 (0.68) ALDH1A1KDM4ERCE1KEAP1NFE2L2
SCHEMBL10249221 0.81 ACLY (0.67) ALDH1A1KEAP1NFE2L2LMNA
SCHEMBL31138226 0.79 FFAR4 (0.64) ALDH1A1MEN1KMT2AKEAP1NFE2L2
SCHEMBL23200344 0.79 FFAR4 (0.64) ALDH1A1MEN1KMT2AKEAP1NFE2L2
SCHEMBL23200290 0.79 CYP2C9 (0.76) ALDH1A1KDM4ERCE1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0938471-B1 THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS AMERICAN CYANAMID CO (US) 2001-12-12 EP disclosed
CN-1240429-A Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors AMERICAN CYANAMID CO (US) 2000-01-05 CN disclosed
EP-0938471-A1 THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS American Cyanamid Company (US) 1999-09-01 EP disclosed
US-5929097-A INHIBIT TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME AMERICAN CYANAMID COMPANY (US) 1999-07-27 US disclosed
WO-1998016503-A2 THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS AMERICAN CYANAMID COMPANY (US) 1998-04-23 WO disclosed